Further screening rounds and longer-term follow-up within the IMPACT study will enable a more complete assessment of the possible benefit and harms of screening in terms of risk of competing mortality and efficacy of early detection and treatment in these men, as well as enabling the assessment of the rates of interval cancers to inform the optimal PSA screening interval. Here, KLK3 is linked to cancer.